IBDEI04Q ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1687,1,4,0)
 ;;=4^R26.9
 ;;^UTILITY(U,$J,358.3,1687,2)
 ;;=^5019309
 ;;^UTILITY(U,$J,358.3,1688,0)
 ;;=R26.0^^3^46^11
 ;;^UTILITY(U,$J,358.3,1688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1688,1,3,0)
 ;;=3^Ataxic gait
 ;;^UTILITY(U,$J,358.3,1688,1,4,0)
 ;;=4^R26.0
 ;;^UTILITY(U,$J,358.3,1688,2)
 ;;=^5019304
 ;;^UTILITY(U,$J,358.3,1689,0)
 ;;=R26.1^^3^46^49
 ;;^UTILITY(U,$J,358.3,1689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1689,1,3,0)
 ;;=3^Paralytic gait
 ;;^UTILITY(U,$J,358.3,1689,1,4,0)
 ;;=4^R26.1
 ;;^UTILITY(U,$J,358.3,1689,2)
 ;;=^5019305
 ;;^UTILITY(U,$J,358.3,1690,0)
 ;;=R20.8^^3^46^59
 ;;^UTILITY(U,$J,358.3,1690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1690,1,3,0)
 ;;=3^Skin Sensation Disturbances NEC
 ;;^UTILITY(U,$J,358.3,1690,1,4,0)
 ;;=4^R20.8
 ;;^UTILITY(U,$J,358.3,1690,2)
 ;;=^5019281
 ;;^UTILITY(U,$J,358.3,1691,0)
 ;;=R20.0^^3^46^8
 ;;^UTILITY(U,$J,358.3,1691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1691,1,3,0)
 ;;=3^Anesthesia of skin
 ;;^UTILITY(U,$J,358.3,1691,1,4,0)
 ;;=4^R20.0
 ;;^UTILITY(U,$J,358.3,1691,2)
 ;;=^5019278
 ;;^UTILITY(U,$J,358.3,1692,0)
 ;;=R20.1^^3^46^38
 ;;^UTILITY(U,$J,358.3,1692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1692,1,3,0)
 ;;=3^Hypoesthesia of skin
 ;;^UTILITY(U,$J,358.3,1692,1,4,0)
 ;;=4^R20.1
 ;;^UTILITY(U,$J,358.3,1692,2)
 ;;=^5019279
 ;;^UTILITY(U,$J,358.3,1693,0)
 ;;=R20.2^^3^46^51
 ;;^UTILITY(U,$J,358.3,1693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1693,1,3,0)
 ;;=3^Paresthesia of skin
 ;;^UTILITY(U,$J,358.3,1693,1,4,0)
 ;;=4^R20.2
 ;;^UTILITY(U,$J,358.3,1693,2)
 ;;=^5019280
 ;;^UTILITY(U,$J,358.3,1694,0)
 ;;=R51.^^3^46^32
 ;;^UTILITY(U,$J,358.3,1694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1694,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,1694,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,1694,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,1695,0)
 ;;=Z86.79^^3^46^55
 ;;^UTILITY(U,$J,358.3,1695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1695,1,3,0)
 ;;=3^Personal history of other diseases of the circulatory system
 ;;^UTILITY(U,$J,358.3,1695,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,1695,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,1696,0)
 ;;=J20.9^^3^47^2
 ;;^UTILITY(U,$J,358.3,1696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1696,1,3,0)
 ;;=3^Acute bronchitis, unspecified
 ;;^UTILITY(U,$J,358.3,1696,1,4,0)
 ;;=4^J20.9
 ;;^UTILITY(U,$J,358.3,1696,2)
 ;;=^5008195
 ;;^UTILITY(U,$J,358.3,1697,0)
 ;;=J21.8^^3^47^1
 ;;^UTILITY(U,$J,358.3,1697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1697,1,3,0)
 ;;=3^Acute bronchiolitis due to other specified organisms
 ;;^UTILITY(U,$J,358.3,1697,1,4,0)
 ;;=4^J21.8
 ;;^UTILITY(U,$J,358.3,1697,2)
 ;;=^5008198
 ;;^UTILITY(U,$J,358.3,1698,0)
 ;;=J44.9^^3^47^11
 ;;^UTILITY(U,$J,358.3,1698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1698,1,3,0)
 ;;=3^Chronic obstructive pulmonary disease, unspecified
 ;;^UTILITY(U,$J,358.3,1698,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,1698,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,1699,0)
 ;;=J44.1^^3^47^10
 ;;^UTILITY(U,$J,358.3,1699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1699,1,3,0)
 ;;=3^Chronic obstructive pulmonary disease w (acute) exacerbation
 ;;^UTILITY(U,$J,358.3,1699,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,1699,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,1700,0)
 ;;=J42.^^3^47^8
 ;;^UTILITY(U,$J,358.3,1700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1700,1,3,0)
 ;;=3^Chronic Bronchitis,Unspec
 ;;^UTILITY(U,$J,358.3,1700,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,1700,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,1701,0)
 ;;=J43.9^^3^47^13
 ;;
 ;;$END ROU IBDEI04Q
